Presentation details results from Biosense Webster’s global, multicenter STELLAR study Irvine, CA – February 3, 2023 – Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi, announced that positive results from the company-sponsored STELLAR study were presented as a late breaker, titled “Pulmonary Vein Isolation of Paroxysmal Atrial […]
Tag: STELLAR
Merck Announces Positive Top-line Results from Pivotal Phase 3 STELLAR Trial Evaluating Sotatercept for the Treatment of Adults with Pulmonary Arterial Hypertension (PAH)
Sotatercept demonstrated significant improvement in exercise capacity and key secondary outcome measures compared to placebo when added to background therapy RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive top-line results from the pivotal Phase 3 STELLAR trial evaluating the safety and efficacy of sotatercept, an […]
Texas Cardiac Arrhythmia Institute of St. David’s Medical Center is the first in the United States to treat patient under study for evaluation of the ablation catheter-balloon for the treatment of atrial fibrillation
AUSTIN, Texas , February 13, 2019 / PRNewswire / – The Texas Cardiac Arrhythmia Institute (TCAI) of St. David’s Medical Center recently conducted the first procedure in the United States using the new multi-electrode radiofrequency (RF) ablation balloon catheter, HELIOSTAR as part of the STELLAR study. The aim of the study is to evaluate the safety and […]
Recent
Virtual Cardiology Program Cuts Cardiac Hospital Readmissions by More Than Half, Study Finds
CARMAT Achieves the Milestone of 100 Implants of Its Aeson® Total Artificial Heart
$5 Million Gift from Lorraine and Bill Dodero Creates One-of-a-Kind Limb Preservation Center at University Hospitals Harrington Heart & Vascular Institute
Popular
- No commented posts yet